View Author

Muller, R.

(Ralf Muller)


stent patient restenosi follow-up angiographic lesion paclitaxel-eluting month angiographic restenosis 2 paclitaxel-eluting stents study in-stent circulation paclitaxel diameter in-stent restenosis procedure analysis trial neointimal neointimal hyperplasia treatment volume segment target taxus iii trial subacute stent thrombosis balloon angioplasty intracoronary group hyperplasia ultrasound result target lesion balloon angioplasty heart implantation 12 months paclitaxel-eluting stent paclitaxel-eluting stents stenosi thrombosis delivery intravascular percent volume obstruction vessel 6 months table coll cardiol 3 patients artery serruy length percent figure cardiol occlusion subgroup diameter stenosis intracoronary gamma-radiation therapy effect 3.5 mm 1 patient information 2 stents outcome 6- month follow-up predefined angiographic criteria value subgroup analysis anginal symptoms comparison artery disease stent thrombosis metal stent neointimal hyperplasia volume ivus assessment angiographic follow-up eur heart j




1 Most Recent Publications

TAXUS III Trial: In-Stent Restenosis Treated With Stent-Based Delivery of Paclitaxel Incorporated in a Slow-Release Polymer Formulation (Article)
Tanabe, K. Degertekin, M. Feyter, P.J. de Serruys, P.W.J.C. Giessen, W.J. van der Smits, P.C. Regar, E.S. Grube, E. Russell, M.E. Selbach, G. Staberock, M. Backx, B.A.M.W. Muller, R. Disco, C. Ligthart, J.M.R.
2003-02-04